MedTrace Logo

Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists

NCT06003985 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 354

Last updated 2025-11-26

No results posted yet for this study

Summary

The aim of this study is to perform bedside gastric point of care ultrasound (POCUS) exams to assess the gastric volume and content (clear liquids vs solid food) perioperatively in patients who take glucagon-like peptide 1 (GLP-1) agonist medications compared to patients who do not take GLP-1 agonists.

Conditions

  • Gastric Ultrasound
  • Glucagon-like Peptide 1
  • Point of Care Ultrasound

Interventions

OTHER

Gastric Ultrasound Exam

A gastric ultrasound is a simple, fast, non-invasive bedside diagnostic test that provides a qualitative and quantitative assessment of gastric contents. There are no known risks of a gastric ultrasound exam.

Sponsors & Collaborators

  • Hospital for Special Surgery, New York

    lead OTHER

Principal Investigators

  • Oliver Panzer, MD · Hospital for Special Surgery, Department of Anesthesiology

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-29
Primary Completion
2025-01-31
Completion
2025-02-01

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06003985 on ClinicalTrials.gov